1. society
2. welfare
3. healthcare
4. hospital

12-14 MAY 2006
Sponsors
Special thanks go to the following companies for
supporting this conference:
AstraZeneca
www.astrazeneca.com
Satellite meeting
B Braun
www.bbraun.com
Poster presentations and awards
Hameln
Pharmaceuticals
www.hameln.co.uk
Organising Committee
Delegate bags
Richard Cattell, GHP
Helen Hodges, UKCPA
Marie Matthews, UKCPA
Teva Hospitals
Guild of Healthcare Pharmacists
Amicus Centre
33 - 37 Moreland Street
London
EC1V 8HA
www.ghp.org.uk
UK Clinical Pharmacists Association
2nd Floor, Alpha House
Countesthorpe Road
Wigston
Leicestershire.
LE18 4PJ
www.ukcpa.org
www.tevahospitals.co.uk
Pre-dinner drinks
The Specials
Laboratory Ltd
www.specialslab.co.uk
Exhibitor’s wine reception
Wockhardt UK
www.wockhardt.co.uk
Delegate badges
Conference organisers
Profile Productions Ltd
Northumberland House
11 The Pavement
Popes Lane
London
W5 4NG
Tel:
Fax:
Email:
Web:
020 88327311
020 88327301
info@profileproductions.co.uk
www.profileproductions.co.uk
2 N D G H P / U K C PA J O I N T C O N F E R E N C E
Welcome
Dear Colleagues
Welcome to the 2nd joint national conference of GHP and UKCPA.
We have a full programme both educationally and socially. We are pleased that
Dr Mike Scott will be addressing the conference on Northern Ireland’s approach
to Medicines Management, and we also welcome back to the UK Ian Coombes, who is currently working in
Queensland and will present the person and system based approach to Medicines Management.
We anticipate a high turnout for the workshops due to the high quality of presenters; the challenge will be how
to select your choice. The key feature of this conference is that the presenters are leading practitioners in their
field, and thus provide the opportunity to help you to improve and develop your own service, as well as
network with like-minded colleagues.
Given the current political climate, there is of course a session on Sunday morning that will tackle the current
professional challenges of the extended role, modernisation and the Agenda for Change.
As ever we will provide a promising social programme, the Friday
evening soiree will be inhouse this year – we hope that you will
take this opportunity to develop social networks with your
colleagues, and at the conference dinner on Saturday night.
The conference promises to be another excellent event and we
hope you enjoy it.
We would like to thank Richard Cattell (GHP), the UKCPA
Education and Programme Committee, Marie Matthews (UKCPA
Office Manager) and her staff, and finally to the conference
organisers, Profile Productions.
Anthony Oxley, President, GHP
Helena Hodges, Chair, UKCPA
Contents
Programme of events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Abstracts and biographies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
- Plenary speakers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
- Workshops . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Exhibitor List . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Exhibition plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Exhibitor information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Evaluation form . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
CONFERENCE PROGRAMME
CONFERENCE
PROGRAMME
4
Friday 12 May
10.30
Satellite meeting (Sponsored by AstraZENECA
Changing times: Recent developments in gastroenterology and
implications for pharmacists
Dr John Anderson, Consultant Gastroenterologist, Cheltenham General
Hospital and Omar Ali, Formulary Development Pharmacist, Surrey and
Sussex NHS Trust
Winchester
12.00
Registration, lunch, exhibition and posters
The Atrium &
Commonwealth Suite
14.00
Chair’s opening and welcome
Anthony Oxley, President, GHP and Helena Hodges, Chair, UKCPA
Royal Suite
14.15
Keynote: Delivering the future in stormy weather
Dr Keith Ridge, Chief Pharmaceutical Officer, Department of Health
14.45
Creating the evidence for medicines management; the Northern
Ireland approach
Dr Mike Scott, Chief Pharmacist, United Hospitals Trust, Northern Ireland
15.30
Refreshments, exhibition and posters
Commonwealth Suite
2006 Award Presentations
Royal Suite
16.15
Pfizer Patient Safety Award: An internet-based medication safety
educational package
Professor Bryony Dean-Franklin, Principal Pharmacist, Clinical Services &
Director, Academic Pharmacy Unit, Hammersmith Hospitals NHS Trust
16.35
Wyeth Education and Training Award: Developing a medicines
management course for pharmacy technicians
Dr Sheila Woolfrey, Chair, Northern Sector Clinical Pharmacy Network
and Lead Pharmacist – Medicine, Wansbeck General Hospital,
Northumbria Healthcare NHS Trust
16.55
IVAX Leadership Award: Development and implementation of a
collegial model of management
Laura O’Loan, Assistant Director, London Pharmacy Education and Training
17.15
Official exhibition opening and wine reception
Anthony Oxley, President, GHP
Sponsored by The Specials Laboratory Ltd
Commonwealth Suite
19.30
Evening entertainment: ‘A taste of Asia’
Sponsored by GHP
Newbury Suite
Saturday 13 May
08.15
Registration, exhibition and posters
The Atrium &
Commonwealth Suite
09.15
Workshop session 1
1A:
Impact of KSF on pharmacy education and training
Dave Thornton, Principal Pharmacist, Clinical Services, University
Hospital Aintree and Richard Cattell, Director, South West Medicines
Information and Training, Bristol Royal Infirmary
Royal 1
1B:
Skills for success: Personal qualities
Charles Marshall, Director, Axis Development
Royal 2
1C:
Poisoning
Marie Blackwell, Emergency Department Directorate Pharmacist,
Royal Sussex County Hospital, Brighton
Richmond
CONFERENCE PROGRAMME
5
Managing Parkinson’s disease
Charles Tugwell, Clinical Pharmacist for Neurosciences and Principal
Pharmacist for Active Medicines Information Service, Royal London Hospital
Connaught
1E:
Effective communication
Andrew Andrews, Health Services Legal Advisor, Bond Solon
Belvedere
1F:
Critical appraisal skills
Angela Emerson, Medicine's Information Pharmacist, Southampton
General Hospital and Iram Hussain, Regional MI Manager – Operations,
London Medicines Information Service
Windsor Salon
1G:
Care closer to home and pharmacist prescribing
Sue Carter, Head of Prescribing and Pharmacy, Adur, Arun &
Worthing PCT and Member of Council, GHP
Edwardian
10.45
Refreshments, exhibition and posters
Commonwealth Suite
11.30
Keynote: Standardised medication management – a person and
system based approach
Ian Coombes, Team Leader, Safe Medication Practice Unit,
Queensland Health and Senior Clinical Lecturer, School of Pharmacy
University of Queensland
Royal Suite
12.30
Lunch, exhibition and manned poster session
Commonwealth Suite
13.45
Workshop session 2
2A:
Assessment of competencies using the KSF
Tess Fenn, Pharmacy NVQ and Technical Staff Development Manager,
and Aamer Safdar, Pre-registration Training Manager, Guys and
St Thomas’ Hospital
Royal 1
2B:
Skills for success: Setting direction
Charles Marshall, Director, Axis Development
Royal 2
2C:
Pneumonia
Nicola Wake, Lead Pharmacist, Medicine, North Tyneside General Hospital
Richmond
2D:
Cardiology
Duncan McRobbie, Principal Clinical Pharmacist, Guy’s and St Thomas’
Hospital Trust
Connaught
2E:
Implementing actions: Tools
Jane Nicholls, Associate Director of Clinical Pharmacy and London
Pharmacist Supplementary Prescribing Lead, Northwick Park Hospital
Belvedere
2F:
The good, the bad, the ugly
Howard Tebby, Senior Commercial Development Manager, Pfizer and
Founder Chairman, GHP Procurement and Distribution Interest Group and
Allan Karr, Pharmacy Business Services Manager, UCL Hospitals Trust,
Procurement and Distribution Interest Group
Windsor Salon
2G:
Care closer to home and medicines management in managed care
Sue Carter, Head of Prescribing & Pharmacy, Adur, Arun & Worthing PCT
and Member of Council, Guild of Healthcare Pharmacists
Edwardian
15.15
Refreshments, exhibition and posters
Commonwealth Suite
15.45
UKCPA Annual General Meeting
Royal Suite
16.15
GHP Meeting
19.00
Drinks reception
Sponsored by Teva Hospitals
The Atrium
19.30
Conference dinner
Commonwealth Suite
CONFERENCE
PROGRAMME
1D:
CONFERENCE PROGRAMME
CONFERENCE
PROGRAMME
6
Sunday 14 May
09.30
Workshop session 3
3A:
The skills escalator and the KSF
Steve Acres, Pharmacy Services Manager, Leicester Royal Infirmary
Connaught
3B:
Succession planning: Experiential development plan
Dr Catherine Duggan, Director, Academic Department of Pharmacy,
Barts and the London NHS Trust, Royal London Hospital, and Pippa
Roberts, Chief Pharmacist, Wirral Hospital NHS Trust and
GHP/UKCPA Leadership Development Group
Royal 2
3C:
Acute coronary syndromes
Jennifer Thomson, Clinical Pharmacist, A&E & Outreach,
Southampton General Hospital
Richmond
3D:
Rheumatology
Dr Christopher Green, Director of Pharmacy and Medicines
Management, Countess of Chester NHS Foundation Trust
Royal 1
3E:
Implementing solutions: Understanding the dynamics of
multidisciplinary team working
Amanda McLean, Quality Assurance Pharmacist, Western General
Hospital, Edinburgh and Chair, UKCPA Quality and Risk
Management Group
Belvedere
3F:
An overview of Colorectal cancer
Jane Ashton, RMH Specialist GI Oncology Pharmacist, and Lynn Shand,
Clinical Services Manager, Royal Marsden NHS Trust
Windsor Salon
3G:
Care closer to home and the interface
Sue Carter, Head of Prescribing & Pharmacy, Adur, Arun & Worthing PCT
and Member of Council, GHP and Dr Duncan Petty, Practice Pharmacist,
North Bradford PCT and Pharmacy Lecturer, University of Leeds
Edwardian
11.00
Refreshments
The Atrium
Current Professional Challenges
Royal Suite
11.30
The future of extending prescribing - a view from outside pharmacy
Professor Tony Avery, Head of Division of Primary Care, University
Hospital Nottingham
11.50
Modernising regulation
Robert Darracott, Director of Strategic & Corporate Development,
Royal Pharmaceutical Society
12.10
Agenda for Change - the next steps
David Miller, Chair, GHP Terms and Conditions Committee and
Chief Pharmacist, Sunderland NHS Foundation Trust
12.30
Closing remarks
12.35
Lunch and departure
ABSTRACTS & BIOGRAPHIES
Plenary speakers
7
to become the regional system, yielding efficiencies to
the healthcare economy of £9.3million over the three
years to 2008.
Delivering the future in stormy weather
Dr Mike Scott
Dr Keith Ridgley
Chief Pharmacist, United Hospitals Trust,
Northern Ireland
Chief Pharmaceutical Officer,
Department of Health
Mike Scott is currently Chief
Pharmacist for United Hospitals Trust in
Antrim. He is Co-director of the
Antrim Hospital Academic Practice Unit with the
School of Pharmacy at Queen’s University, Belfast. He
is Chairman of the G6 Pharmacy Directors Group and
Vice-chairman of the Regional Pharmaceutical
Contracting Executive Group, also representing the
province on the National Pharmaceutical Supplies
Group. He is also a member of the Infectious Diseases
Regional Research Group, Regional Group on Specialist
Drugs in Northern Ireland and Project Manager for
Therapeutic Tendering and Pharmaceutical Clinical
Technology, two of the eight schemes under the
regional Pharmaceutical Services Improvement
Programme.
Pfizer Patient Safety Award: An internet-based
medication safety educational package
Background
Creating the evidence for medicines management;
the Northern Ireland approach
Integrated medicines management comprises all of
the key elements involved in checking patients drugs
from admission to discharge, ensuring good
communication across the primary/secondary care
interface. The traditional system lacked this latter
component as well as having other significant
deficiencies, for example in relation to the accuracy of
medication history, medication errors during the
inpatient stay. It was estimated that medicines related
problems cost in the region of £40million per year in
Northern Ireland. However, there was a lack of robust
data to prove that investment in clinical pharmacy
services would improve this situation.
Funding was obtained and put in place to enable the
employment of a team of five pharmacists and five
technicians, together with research support from the
School of Pharmacy at Queen’s University of Belfast.
The results obtained demonstrated that there was
reduced length of stay, decreased readmission rates,
reduced wastage of patients’ own drugs, more
accurate drug history, improved medicines use, better
use of doctor and nurse time and more accurate
discharges and improved stock utilisation. The net
effect was to yield a return of between £4.80 and £8
for every pound invested.
Two further elements, which are now integral parts of
the process, were the development of electronic
lockers and EPICS®, a PDA-based pharmacy
intervention and activity system, which is now regional
in Northern Ireland.
On the basis of this work, a total of £4.6million is, and
will be, invested in pharmacy staff to allow this model
Medication administration errors (MAEs) occur in 38% of all non-intravenous (IV) doses. Educational
interventions are often advocated, but classical
approaches such as group education sessions are often
impractical in clinical practice. We therefore designed
and evaluated an internet-based educational
programme on medication safety.
Methods
The study took place on a medical ward. The
programme consisted of eleven modules developed by
trust staff, delivered using commercial software. MAEs
were identified using observation of medication
administration, before and after asking nursing staff on
the study ward to complete the package. The
denominator used to calculate MAE rates was the
number of opportunities for error (OE), defined as any
dose of medication observed being administered (or
omitted).
Results
Twelve of the 19 nurses completed all modules (mean
9.3 modules per nurse). 1188 OE were observed
during pre-intervention, and 1397 afterwards. Eightytwo errors (6.9%) were identified pre-intervention and
seventy-three (5.2%) afterwards (95% confidence
interval (CI) for the difference -3.6 to 0.2%). MAE
rates for non-IV drugs were 6.1% pre-education, and
4.2% afterwards (CI -0.2 to -3.6%).
Conclusion
There was a high rate of uptake amongst nursing staff,
suggesting this is a practical approach for routine
practice. A significant reduction in non-IV MAEs was
observed.
ABSTRACTS &
BIOGRAPHIES
Dr Ridgley registered as a pharmacist
in 1988 having trained at the School of
Pharmacy, University of London. His
PhD (University of Manchester) was informed by the
evaluation of pharmacy automation. Dr Ridgley has
worked at most levels in hospital pharmacy, his last
two posts being Chief Pharmacist at North Glasgow
University Hospitals and University Hospital
Birmingham NHS Foundation Trust. Whilst in Glasgow,
he was part of the National Pharmaceutical Forum,
which advised the Chief Pharmaceutical Officer for
Scotland and a member of the Scottish Medicines
Consortium. In Birmingham, Dr Ridgley was working
on a new patient centred model for pharmacy services
before taking up his current post on 1 March 2006.
Dr Ridgley has also worked in community pharmacy
and the pharmaceutical industry, as well as an earlier
spell at the Department of Health as professional lead
on prescribing and hospital pharmacy.
8
ABSTRACTS & BIOGRAPHIES
Professor Bryony DeanFranklin
Dr Sheila Woolfrey
Chair, Northern Sector Clinical Pharmacy
Network and Lead Pharmacist –
Medicine, Wansbeck General Hospital,
Northumbria Healthcare NHS Trust
ABSTRACTS &
BIOGRAPHIES
Principal Pharmacist Clinical Services and
Director, Academic Pharmacy Unit,
Hammersmith Hospitals NHS Trust
Professor Franklin is Principal
Pharmacist for Clinical Services and Director of the
Academic Pharmacy Unit, Hammersmith Hospitals
NHS Trust. The Academic Pharmacy Unit is a joint
initiative between the Trust and the School of
Pharmacy, University of London.
Bryony has been involved with medication error research
for more than ten years, and together with colleagues
from the School of Pharmacy, has published widely on
methods for studying errors, and the frequency and
causes of prescribing, dispensing and medication
administration errors. More recently she has been
involved with the evaluation of various technologies
designed to reduce errors. Her current post combines
research, education and training, and clinical practice.
Wyeth Education and Training Award:
Developing a medicines management course
for pharmacy technicians
The shortage of pharmacists and opportunities for
employment in different sectors of the profession, has
led to the role-development of pharmacy support staff.
This, with the use of skill-mix and the re-engineering of
the pharmacy services, has changed the roles of the
pharmacy team at ward level. In addition, the training
needs identified by the technicians themselves needed
to be addressed before the skill-mix could be taken
further at ward level, thus allowing the technicians
perform a basic clinical screening of prescription charts.
The Northern Sector Clinical Pharmacy Network, the
Northern Sector Technician CPD Strategy Group and
the regional Pharmacy Education & Training Office
designed a regional scheme standardising training,
providing the relevant theoretical underpinning
knowledge and practical skills.
Pharmacists and technicians reported the positive
benefits to patient care and the wider healthcare
team. The technicians have taken on new roles such
as drug history taking, advising, educating and
counselling patients.
Whilst trust in-house training schemes exist, this
programme ensures that technicians are trained to a
consistent standard. Participating trusts know what is
covered, and what the technicians are capable of
doing on the wards.
We are currently working towards getting the course
accredited by Sunderland University.
Dr Woolfrey graduated from Leicester
School of Pharmacy, and after a pre-reg in Nottingham,
went on to read for a PhD in Pharmacology at The
Welsh School of Pharmacy, Cardiff.
Dr Woolfrey then worked for a short time at Bedford
General Hospital before moving to the North East of
England. She has worked at Ashington in a number of
different positions and currently holds the post of Lead
Pharmacist for Medicine at Wansbeck General Hospital,
Northumbria Healthcare NHS Trust. Dr Woolfrey is a
Fellow of the College of Pharmacy Practice and an
Honorary Lecturer at the University of Sunderland and
will be giving this presentation as Chair of the
Northern Sector Clinical Pharmacy Network.
IVAX Leadership Award: Development and
implementation of a collegial model of
management
Background
LPE&T, a regional NHS pharmacy education and training
organisation, had evolved into four "self-directed teams" 1,
which some staff perceived to work in isolation.
Objectives
1. To develop a shared view of the future role and purpose
of LPE&T and to consider ways of achieving these.
2. To implement a “collegial” model of management2
where all members “have the potential to add to the
leadership of the team”1.
Methods
1. “Non-senior” team members were invited to an
Open Discussion Forum (ODF), and asked to complete
a questionnaire at the end of the session.
2. ODF suggestions were discussed and agreed by the
whole team at subsequent team meetings.
Results
1. ODF participants agreed that we had started to
develop a shared view of the future role and purpose of
LPE&T and considered possible ways of achieving these.
2. New “network” teams have been established to
improve collaboration across the whole service3.
Conclusions
1. The whole team was involved in the development of
a shared vision for LPE&T.
2. LPE&T has implemented a collegial model of management
that harnesses the expertise within the whole team.
References
1
Horner M. Leadership theory reviewed. In Bennett N, Crawford M,
Cartwright M, editors. Effective Educational Leadership. London: Paul
Chapman Publishing; 2003: 27-43
2
Leithwood K, Jantzi D, Steinbach R. Fostering teacher leadership. In
Bennett N, Crawford M, Cartwright M, editors. Effective Educational
Leadership. London: Paul Chapman Publishing; 2003: 186-200
3
Augier M, Vendelø MT. Networks, cognition and management of tacit
knowledge. In Bennett N, Crawford M, Cartwright M, editors. Effective
Educational Leadership. London: Paul Chapman Publishing; 2003: 74-88
ABSTRACTS & BIOGRAPHIES
Laura O’Loan
Ian Coombes
Assistant Director, London Pharmacy
Education and Training
Team Leader, Safe Medication Practice
Unit, Queensland Health and Senior
Clinical Lecturer, School of Pharmacy
University of Queensland
Standardised medication management – a
person and system based approach
Australia’s National Medicines Policy, the
Pharmaceutical Advisory Council’s Guiding Principles
to Achieve Continuity in Medication Management,
and the Health Ministers agreements on patient safety
initiatives, have set the agenda for change in
medicines management.
Ian will discuss multiple medication system changes
developed as a result of medication incident analysis
and observational studies of medication management
by the medication safety team at the Princess
Alexandra Hospital, Brisbane. This work lead to a
component of Queensland Health’s Safe Medication
Practice Unit that has developed, evaluated and
implemented standardised medication and fluid
charts, now implemented across Queensland public
hospitals. This has been achieved through a
collaborative state wide approach to medication safety.
Educational programs for nursing, medical and
pharmacy teams, and decision support tools for high
risk drugs have been developed and implemented.
Evaluation has demonstrated reductions in prescribing
and administration errors and significant correlation
with increased patient safety. Other state wide
medication system changes have included state wide
electronic medication liaison systems.
As a component of his PhD, Ian has developed a
problem based safe medication curriculum for medical
staff which is being evaluated and rolled out across
Queensland. A state wide medication risk awareness
program for nurses has also been rolled out. Both the
standardised medication systems and training
programs have been adopted nationally and form a
part of a national medication safety program.
Ian graduated from the London School
of Pharmacy and worked in London and Brighton as a
clinical service manager and specialist practitioner.
Since 1996, he has been at the Princess Alexandra
Hospital (PAH) where he was in charge of clinical
services. At PAH he established the first
multidisciplinary medication safety team. In 2003, Ian
was awarded the Australian Clinical Pharmacy Award
by the Society of Hospital Pharmacists. He is currently
a senior pharmacist with the Safe Medication Practice
Unit, a clinical senior lecturer at the School of
Pharmacy and is studying for his PhD, which is
evaluating the impact of a combined system and skills
based approach to reducing prescribing errors.
The future of extending prescribing - a view
from outside pharmacy
In 2005 the Department of Health consulted on
options for extending nurse and pharmacist
prescribing.1,2 In November they announced that nurse
and pharmacist independent prescribers will be able to
prescribe any licensed medicine except controlled
drugs – the most radical of the options considered.3
What is being proposed is one of the most farreaching extensions of prescribing by nurses and
pharmacists anywhere in the world.
In this presentation, I will expand on the messages
delivered in my BMJ editorial on extended prescribing4
to cover the following:
Background to extended prescribing – how has this
come about?
Debate on the pros and cons for extended
prescribing
The challenges for extended prescribers
How is extended prescribing likely to work in the
real world?
References
1
Consultation on options for the future of independent prescribing by
Extended Formulary Nurse Prescribers.
http://www.dh.gov.uk/assetRoot/04/10/40/58/04104058.pdf
(accessed 14th November, 2005).
2
Consultation on proposals to introduce independent prescribing by
pharmacists.
http://www.dh.gov.uk/assetRoot/04/10/48/81/04104881.pdf
(accessed 14th November, 2005).
3
Nurse and Pharmacist prescribing powers extended.
http://www.dh.gov.uk/PublicationsAndStatistics/PressReleases/PressR
eleasesNotices/fs/en?CONTENT_ID=4122999&chk=Mjc1MS
(accessed 14th November, 2005).
4
Avery AJ, Pringle MAL. Extended prescribing by UK nurses and
pharmacists. BMJ 2005;331:1154-1155.
ABSTRACTS &
BIOGRAPHIES
Laura registered with the Royal
Pharmaceutical Society of Great Britain in 1987. She
worked in hospital pharmacy in London for ten years,
gaining an MSc in Clinical Pharmacy from London
University in 1990. In 1997 she began work at London
Pharmacy Education & Training (LPE&T), a regional
NHS pharmacy education and training organisation,
and became Assistant Director of LPE&T in 2004. In
2005, she completed an Open University MA in
Education, and moved to Northern Ireland. She has
recently finished a fixed term contract as Acting
Assistant Director at the Northern Ireland Centre for
Postgraduate Pharmaceutical Education and Training
(NICPPET).
9
ABSTRACTS & BIOGRAPHIES
ABSTRACTS &
BIOGRAPHIES
10
Professor Tony Avery
Agenda for Change - the next steps
Head of Division of Primary Care,
University Hospital Nottingham
Agenda for Change was first implemented in June
2003 after years of “secret” negotiations behind closed
doors. Three years on, the system remains
incomplete, subjected to ongoing testing and delays
and despite providing individuals with more money,
more holidays and a reduced working week, it seems
to have caused major disruption and discontent
amongst NHS employees. Through the use of job
evaluation and the Knowledge and Skills Framework it
was to provide the tools to deliver a modern and
highly skilled workforce for the strategic challenges
ahead. Yet, NHS organisations have major financial
angst and posts are being reduced in a number of
trusts, in part, it is claimed due to these changes.
Professor Tony Avery is Head of the
Division of Primary Care at the University of
Nottingham. He is also works as a general practitioner
in Nottingham. Tony’s main research focus is on
prescribing and he has a particular interest in
improving the safety of medicines use in primary care.
Tony has advised the DoH and RPSGB on issues
relating to extended prescribing by nurses and
pharmacists and wrote a recent editorial on the
subject (BMJ 2005;331:1154-1155).
Tony is a member of the NPSA Expert Prioritisation
Panel and the BNF’s Joint Formulary Committee. He is
Consultant Editor of Prescriber.
Modernising regulation
The reform of health professional regulation has a long
history with the current Government. The first NHS
Plan in 2000 told regulators they would have to have a
larger proportion of lay members on our Councils,
develop quicker fitness to practise procedures, and
become more responsive.
Pharmacy was never going to be exempt from this
process, and the Royal Pharmaceutical Society seized
the opportunity to present to Government its wish list
for reform, based on hundreds of decisions, to inform
the drafting of the new legislation.
The Section 60 Order – the public consultation is live
now – will replace the Pharmacy Act 1954. It has
been designed to dovetail with the Society’s new
Charter, which deals mainly with the professional body
functions and the internal ordering of the Society. The
Order, on the other hand, is reserved for all the things
that regulatory bodies have to do by statute –
including standard setting, education standards,
registration and fitness to practise.
The Charter and legislation both provide the Society
with powers, which will be implemented through a
subordinate layer of governing documents. This
session will address two main questions: “What does
all this mean?” and “Why is it important?”
Robert Darracott
Director of Strategic & Corporate
Development, Royal Pharmaceutical Society
At the RPSGB, Rob heads up a
directorate responsible for human
resources, central administration,
research and policy development. He
joined the Society in 2003 from Alliance UniChem Plc,
where he was the member of the European business
development team, having worked for five years for
AU’s UK chain Moss, where his service development
activities led to runner-up prizes in the Pharmaceutical
Care Awards in both 2002 and 2003. Rob’s prior
career includes a spell in the Department of Health.
He is a periodicals qualified journalist, and in the dim
and distant past was a resident hospital pharmacist.
Whilst individual staff are keen to maximise the
potential of job evaluation outcomes, maintain their
out-of-hours payments and seek where possible parity
with those in the commercial sector through
recruitment and retention payments. Service
managers seek a coherent career framework within
competing priorities and increasing financial pressure
with major concerns on how to maintain, never mind
develop pharmaceutical services and improve patient
care on a 24/7 basis.
This personal viewpoint from a national and local level
outlines the challenges and pitfalls ahead and
considers how pharmacists and their managers can in
partnership take the next steps required.
David Miller
Chair, GHP Terms and Conditions
Committee and Chief Pharmacist,
Sunderland NHS Foundation Trust
David Miller is currently Chief
Pharmacist at City Hospitals,
Sunderland NHS Foundation Trust, one
of the twelve original Early Implementer sites. He has
been involved at a national level in all the pharmacist
profiles, consideration of the out-of-hours proposals
and the recent recruitment and retention submission
through GHP and Amicus. He recently realised that he
needed to expand his social horizon when his wife and
family claimed he should have been called Anthony
Francis Charles or AFC Miller.
ABSTRACTS & BIOGRAPHIES
Workshops
1A: Impact of KSF on pharmacy
education and training
11
management which is proactive, positive and focused
on achieving quality outcomes to complex situations.
It will describe how effective leaders develop credibility
and model the way for others to follow
Charles Marshall
The workshop is aimed at delegates who have a good
understanding of the KSF, its implementation and the
creation of KSF outlines.
Dave Thornton
Director, Axis Development
With an academic background in
psychology and economics and a
professional background in sales and
marketing, Charles has spent the last
eighteen years in a variety of management positions. A
great deal of this work has centred upon the
development of individuals within organisations and
the creation and maintenance of effective teams.
Experience within the pharmaceutical industry has led
to a high awareness of the issues currently facing the
NHS. This led to Charles becoming a Co-founder of
Axis Development, an organisation which has supplied
training and development to more than 5,000
healthcare professionals over the last six years. In 2005,
Axis Development became part of the Health Skills
Group with a view to providing an even wider training
and consultancy service for healthcare professionals.
Highly influenced by modern management ideology, his
main focus is on personal development, performance
and achievement by developing successful leadership
strategies and empowering attitudes.
Principal Pharmacist, Clinical Services,
University Hospital Aintree
Dave is the principal clinical pharmacist at
University Hospital Aintree in Liverpool
and vice chair of the Terms and
Conditions Committee for the Guild of Healthcare
Pharmacists. Aintree was an early implementer site for
agenda for change and Dave has been the staff side
accredited representative for pharmacists since March
2003. He is also the joint GHP lead for the knowledge and
skills framework and has been involved in the production of
national and local guidance around the development of
KSF outlines and how to implement the KSF.
Richard Cattell
Director, South West Medicines
Information and Training, Bristol Royal
Infirmary
1B: Skills for success: Personal qualities
The personal qualities and values are at the core of
The Leadership Qualities Framework. The scale and
complexity of the change agenda and the level of
accountability means that NHS leaders need to draw
deeply upon their personal qualities to see them
through the demands of the job.
This workshop will focus on the components of selfawareness, self-management and personal integrity
and how these can be used to develop an approach to
1C: Poisoning
This session will be a general approach to drug
intoxication in adults with some specific examples.
The session is aimed at pharmacists working in areas
such as Medical Assessment Units, Accident and
Emergency departments, Clinical Decision Units, High
Dependency Units and General Medical Wards.
Accidental and intentional poisonings or drug
overdose constitute a significant source of aggregate
morbidity and mortality and health care expenditure,
although the true incidence is unknown due to under
diagnosis and underreporting.1 Poison exposures
account for 5 to 10 percent of all emergency
department visits and greater than 5 percent of adult
Intensive Care Unit admissions.2
The aim of the session is for participants to learn how to
improve the initial management of patients with poisoning.
Participants will be able to identify common features of
presentations due to poisoning and outline common
products involved in poisoning. The workshop will also
enable participants to describe the complications of
poisoning and the therapeutic management of common
poisons encountered in the Emergency setting, and
discuss the role of the Pharmacist in the management of
poisoning. We will also look briefly at access to antidotes
and plans for dealing with mass poisoning.
References:
1
Litovitz, TL, Klein-Schwartz, W, Rodgers, GC, et al. 2001. Annual
Report of the American Association of Poison Control Centres Toxic
Exposure Surveillance System. Am J Emerg Med 2002;20:391
2
Proudfoot, A. Acute poisoning: Principles of Management. Med Int
1989; 61:2499
ABSTRACTS &
BIOGRAPHIES
This workshop will build on the delegates knowledge of
the KSF and the implementation within their local trust.
We will explore three main areas during the workshop
i) What barriers there are (or will be) preventing each
NHS employee from having a KSF development
review to an acceptable standards
ii) Discuss the implementation at one or two specific
sites as comparison and the variety of advice there
is available to managers constructing KSF outlines
iii) What will be the implications - locally (within a
department), organisationally (will the trust use the
information generated, what possibilities are there)
and strategically, (can education providers use
information from KSF outlines to drive their agendas)
iv) What could and should education providers being
doing now and in the future? (What must
pharmacy sort out for itself, what opportunities and
threats does the KSF create?)
ABSTRACTS &
BIOGRAPHIES
12
ABSTRACTS & BIOGRAPHIES
Marie Blackwell
Charles Tugwell
Emergency Department Directorate
Pharmacist, Royal Sussex County
Hospital, Brighton
Clinical Pharmacist for Neurosciences and
Principal Pharmacist for Active Medicines
Information Service, Royal London
Hospital
Marie is currently the Emergency
Department Directorate Pharmacist at the Royal Sussex
County Hospital in Brighton. She has been in this role
for almost two and a half years. As a new position,
Marie has been able to develop the role,
concentrating on developing autonomous practice for
nurses using PGDs, seeing patients admitted to
hospital via the emergency department, attending
ward rounds, teaching staff, risk management and
development and implementation of guidelines.
The Royal Sussex County Hospital has close ties with
the University of Brighton pharmacy and medical
undergraduate courses and Marie is involved in
student training.
Marie studied at the University of Brighton from 19951998 and conduced her pre-registration in community
pharmacy with the National Co-Operative Chemists in
Roehampton.
1D: Managing Parkinson’s disease
Parkinson’s disease is a common neurological
condition affecting around 1% of people over the age
of 65, increasing to 10% in people over the age of 80.
Although it more frequently affects older people, one
in 20 of those diagnosed with Parkinson’s disease in
the UK are less than 40 years old.
Drug therapy is often complex and presents many
challenges. It requires tailoring to the individual’s
response and careful adjustments may be necessary to
minimise troublesome adverse effects which may
develop as a result of drug treatment.
In addition to the management of effects on motor
function caused by Parkinson’s disease, drug therapy is
often needed for a range of other important
symptoms associated with the condition.
The National Service Framework for Long-term
Conditions focuses on improving the care available to
patients with conditions such as Parkinson’s disease.
Since drug therapy plays a key part in the management
of this disease, the potential role for pharmacists both
in hospitals and the community is enormous.
This workshop will provide an overview of the disease
and its management, including drug treatment
strategies. Participants will explore ways of maximising
the input which pharmacists can make to ensure
patients receive optimal drug therapy.
Charles Tugwell has worked at The
Royal London Hospital in drug information services for
more than 25 years. When Barts and The London NHS
Trust was formed in the 1990’s he became responsible
for these services trust-wide. In more recent years,
Charles has focused his attention on developing drug
information systems on the Trust’s intranet. In parallel
with his work in the field of drug information, Charles is
also a Clinical Pharmacist in Neurology and
Neurosurgery. Again, this experience has developed
over many years and involves work with both inpatients
and outpatients. He has a particular interest in the
management of multiple sclerosis and Parkinson’s
disease, and is a member of the Department of Health’s
Long-term Conditions NSF Stakeholder Group.
1E: Effective communication
A good therapeutic outcome is dependant on mutual
trust and respect between health professionals and
patients working in partnership. Underpinning that
trust is effective communication.
Communication is a two-way process – transmitting and
receiving. All too often, health professionals are good at
transmitting data but do not stop to validate that the
message has been received and understood or to hear
what the patient says. The Health Service
Commissioner’s Office comments on the fact that,
almost without exception, complainants when talking to
their investigating officers say ‘this is the first time
anybody has listened to me’. Bearing in mind that the
Office only becomes involved when the entire NHS
complaints procedure has been exhausted, it is a sad
indictment on the ability of staff to manage that process.
Those making a complaint need a sympathetic and
understanding ear, as close to the situation and event
as possible. A reassurance that the matter will be
taken seriously and an undertaking to come back with
an answer once the necessary investigations have been
completed. In general, complainants require an
acknowledgement of what has occurred, an
explanation, an apology if appropriate and an
indication of what steps the organisation has taken to
try to prevent a recurrence in the future.
Andrew Andrews
Health Services Legal Advisor,
Bond Solon
Mr Andrews is a respected legal
advisor, whose practice is and has been
in the public service (predominantly in
health) and an established and
recognised medico-legal trainer. His present
responsibilities comprise: Chairman Standing Panel of
Inquiry and Medico-Legal Advisor for St John
Ambulance, Legal Advisor to an NHS Foundation Trust,
Director of Medico-Legal Group at Bond Solon
Training and Director & Trustee Attend.
ABSTRACTS & BIOGRAPHIES
1F: Critical appraisal skills
The recent changes to the regulations governing
pharmacist prescribing, and the imminent extension to
independent prescriber status, are enablers for primary
and secondary care pharmacists to expand their role
and move services closer to the patient.
The aim of this workshop will be to consider how
pharmacist prescribing will enable change in services
and improved care for patients. By the end of this
session, delegates will understand the potential for
pharmacist prescribing in care pathways and the
enablers and barriers to fulfilling the potential for
pharmacist prescribers. Delegates will also take away
ideas for how to make this happen in reality
Sue Carter
Angela Emerson
Medicine's Information Pharmacist, Southampton General
Hospital
Angela has worked as a Medicines Information
Pharmacist at the Regional Medicines Information
Centre at Southampton General Hospital for nine
years. Previously she has held posts with the Drug
Safety Research Unit, Southampton as a researcher
studying the safety of new drugs in secondary care
practice. She has sat on her local research ethics
committee for five years, and her current research
interests include supporting prescribers ‘out-of-hours’
with accurate information and advice about medicines.
She is currently a part-time student with the School of
Health Sciences and Social Work at the University of
Portsmouth, studying Health Research and Design.
Iram Hussain
Regional MI Manager – Operations,
London Medicines Information Service
Iram Husain qualified from Kings
College London with a pharmacy
degree in 1996. She went on to work
at the Royal Brompton Hospital as Medicines
Information (MI) and Clinical Trials Pharmacist.
Iram specialised in MI at the Chelsea and Westminster
Hospital and her work developed further when she
joined the London Medicines Information Service
(based at Northwick Park Hospital), as Principal MI
Pharmacist. Iram went on to become the Regional MI
Manager for the service and, more recently, Acting
Assistant Director for the region.
Iram provides basic critical appraisal skills training to
varied audiences. She uses her skills daily to evaluate
literature for regional and national material. Iram has
also attended a two-day course run by the National
Training and Research Appraisal Group.
1G: Care closer to home and
pharmacist prescribing
How can pharmacist supplementary prescribing and
future independent prescribing status be used to
support patients with a long term condition e.g.
hypertension in renal failure, AF and warfarin clinics,
Heart failure etc?
Head of Prescribing and Pharmacy, Adur, Arun &
Worthing PCT and Member of Council, Guild of
Healthcare Pharmacists
Sue Carter is Assistant Director at Adur, Arun &
Worthing tPCT with responsibility for Medicines
Management, Prescribing and Pharmacy, and as a PCT
Locality lead for Practice Based Commissioning. Sue is
co-founder of Primary Care Pharmacists’ Association,
which supports and promotes professional
development, networking and advocacy of the primary
care field of pharmacy practice throughout the UK.
2A: Assessment of competencies
using the KSF
Participants will be provided with an overview of the
KSF development review process and the recording
requirements. Participants will also be provided with the
opportunity to identify the skills required to enable valid
assessment of workplace evidence against KSF outlines.
A number of case studies will be provided for
discussion in small groups and will include a number
of issues relating to the assessment of the KSF from an
appraiser and an appraisee’s perspective. The case
studies will provide a practical application of the KSF
during development reviews and provide opportunities
for identifying acceptable evidence required to meet
both core and specific KSF dimensions. Issues of
acceptable evidence will be discussed both in the case
studies and in a wider group discussion. Difficulties
and barriers to the use of KSF will be discussed. At the
end of the case studies there will be a wide group
discussion on the application of the KSF where
personal experiences will be shared.
The workshops will be suitable for all types and grades
of staff from any sector of pharmacy where differences
in available evidence to meet dimensions and
indicators will be identified and discussed.
Tess Fenn
Pharmacy NVQ and Technical Staff
Development Manager, Guys and St
Thomas’ Hospital
Qualifying in 1972, Tess has worked in a
variety of pharmacy sectors; hospital,
academia, community, PCT and currently
practises as the Pharmacy NVQ and Technical Staff
Development Manager within the Pharmacy Education
ABSTRACTS &
BIOGRAPHIES
Don’t know your POOs from your DOOs or your ARRs
from your NNTs? This beginners’ session aims to
explain everything you need to know about critical
appraisal but were too afraid to ask. Using real-life
examples, the session will give you lots of useful tips
when trying to interpret evidence about medicines,
and highlight some of the pitfalls to avoid. The
emphasis of this clinically oriented session is how
critical appraisal can fit into your day-to-day practice;
it is not intended as a master class in statistics –
although we may help to demystify p.
13
ABSTRACTS & BIOGRAPHIES
14
ABSTRACTS &
BIOGRAPHIES
and Development Unit at Guy’s and St Thomas NHS
Foundation Trust. Tess is also the Association of Pharmacy
Technicians UK National Education Officer.
Within her capacity, both with the association and her
current job, she became involved in AfC at the Guy’s and
St Thomas EI site, helping to develop the national
pharmacy technician profiles. She continues to support
the NHS modernisation programme by committing to the
implementation of the Knowledge and Skills framework
within pharmacy nationally and jointly leads on CPD
within the Guy’s and St Thomas’ pharmacy department.
Aamer Safdar
Pre-registration Training Manager, Guys
and St Thomas’ Hospital
Qualified in 1995, Aamer has worked
mainly in hospital pharmacy and at
Guy’s and St Thomas’ NHS Foundation
Trust. Aamer spent his formative years at Guy’s and St
Thomas’. He then took a year out to undertake a fulltime MSc in clinical pharmacy at the School of
Pharmacy and rejoined the Trust to work in the
education and development team. Aamer completed a
PGCE and is in the final year of an MA in Management.
In his current role, Aamer is the pre-registration
training manager and the joint lead for CPD in the
department. Aamer has been involved with the NHS
KSF both locally and nationally and has been involved
with writing KSF outlines for pharmacy staff.
2B: Skills for success: Setting direction
The outstanding leader sets a vision for the future,
drawing on their political awareness of the health and
social care context. This political astuteness and their
vision for the future is underpinned by intellectual
flexibility. Coupled with drive for results, this sense of
seizing the future is key in inspiring and motivating
others to work with them.
This workshop will examine the components of
principle centred organisations and look at the need
for alignment between individual and organisational
values. It will look at the importance of being forward
looking and developing a vision of the future that
others can subscribe to.
Charles Marshall
Director, Axis Development
See biography on page 10
2C: Pneumonia
Community acquired pneumonia is associated with
significant morbidity, mortality and utilisation of health
service resource in the UK. Annual incidence is five to
eleven per 1,000 adult population and between 22%
and 42% are admitted to hospital. The reported
mortality of adults admitted to hospital with
community acquired pneumonia varies between 5.7%
and 12%; this rises to over 50% for adults requiring
admission to an ICU.
This workshop will focus on the management of
pneumonia in the acute admission, including the role
of non-invasive ventilation. Participants will also
consider the role of the pharmacist in both direct and
indirect patient care.
Nicola Wake
Lead Pharmacist, Medicine, North Tyneside General Hospital
Educated at the University of Nottingham, Nicola
Wake qualified following a pre-registration year at
Leicester General Hospital in 1994. Following her
clinical diploma, she specialised in surgery and
anaesthetics, working in both Leicester and Derby as a
Directorate Pharmacist. As Chair of the UKCPA
Surgery and Theatres Pharmacists' Group her email
address was known to over 300 pharmacists as the
electronic newsgroup flourished.
Nicola moved to North Tyneside General Hospital in
2000 where she is currently the Lead Pharmacist for
Medicine. Following a part-time secondment to the
Emergency Services Collaborative, she launched the
UKCPA Emergency Care Pharmacists' Group, providing
a network for pharmacists working in A&E, admissions,
ambulance services and at the interface.
Nicola's other interest is risk management; she
established a Trust wide Medicines Management
Committee, of which she is now professional secretary,
and is currently striving to introduce a joined up
approach to the many aspects of adverse drug events
across Northumbria Healthcare NHS Trust, a complex
organisation with three general hospitals and seven
community hospitals.
2D: Cardiology
Duncan McRobbie
Principal Clinical Pharmacist, Guy’s and
St Thomas’ Hospital Trust
Duncan McRobbie registered as a
pharmacist in 1984 and received his
Masters in Clinical Pharmacy from Brighton University
in 1993. He is currently Principal Clinical Pharmacist
and Cardiac Pharmacist at Guy's and St Thomas' NHS
Foundation Trust in London. He also is a CHD
Pharmacy Advisor for London, Eastern and South East
Specialist Pharmacy Services.
Duncan’s role at GSTT include co-coordinating and
developing the clinical pharmacy service to the Trust
and ensuring best use of medicines. In his specialist
area of practice, Duncan works to ensure patients with
cardiac disease receive optimal pharmaceutical care.
He also works in a GP practice undertaking medication
review for patients with coronary heart disease.
Duncan teaches extensively on coronary heart disease
to undergraduates and postgraduates from all
professions, and is an honorary clinical lecturer at both
London School of Pharmacy and Kings College.
ABSTRACTS & BIOGRAPHIES
In his regional role he advises on use of medicines and
pharmacy service developments across London, and
facilitates exchange of ideas from all sectors of pharmacy.
He is the immediate past chair of the United Kingdom
Clinical Pharmacy Association Cardiology Practice interest
group and is vice chair of this organisation. He is a
member of the DoH CHD Workforce Development Group.
2E: Implementing actions: Tools
The aim of this session is to introduce a tool to analyse
the risks associated with a process. At the end of the
session participants will be able to:
describe process mapping
discuss its usefulness
identify the possible effects of implementing changes
This workshop will use a Failure Modes and Effects
Analysis (FMEA) tool to analyse a familiar process, what
could go wrong , how likely it is that failures could
occur, whether failures would be detected and how
likely it is that harm would result. Participants will also
look at possible changes to the process that would
reduce the chances of failure or minimise their effects
and how these changes would affect the analysis.
Jane Nicholls
Associate Director of Clinical Pharmacy
and London Pharmacist Supplementary
Prescribing Lead, Northwick Park
Hospital
Jane has many years experience
working as a clinical pharmacist in the
NHS in England, particularly in critical care. For the
past five years she has worked for the London, Eastern
and South East Specialist Clinical Pharmacy Service
and specialises in the area of medication-related
adverse events. She has published and presented at
national and international conferences. Jane currently
teaches pharmacists on postgraduate studies about
medication-related risk, and she has done a lot of work
in relation to prescribing.
Jane is a member of the Guild of Healthcare
Pharmacists and a member of the United Kingdom
Clinical Pharmacy Association.
2F: The good, the bad, the ugly
A critical element of medicines management involves the
implementation of an efficient medicines supply chain.
The medicines market has by definition a requirement
for a close and functioning relationship between key
professionals in the NHS and the pharmaceutical
industry. All organisations in the supply chain will tend
to perform many of their operational functions well,
whilst others less so. This “truth” would be the case
whether the organisation was a public sector one,
such as the NHS, or a private sector one such as the
pharmaceutical industry.
Performance management is an important part of this
process of developing and building relationships. For
effective medicines management it is therefore critical
to identify areas where both parties can develop their
health care services or products.
The workshop has been planned to examine the
current effectiveness of the relationship from both the
NHS and the pharmaceutical industry perspective.
Close examination will be given to both organisations
as to what works well and what doesn’t. Areas of
particular concern will be highlighted. The proposed
outcome should hopefully derive a number of lessons
that can be learnt, as well as clarifying possible
opportunities to improve relationships being taken.
Howard Tebby
Senior Commercial Development
Manager, Pfizer and Founder Chairman,
GHP Procurement and Distribution
Interest Group
As a Hospital Pharmacist for 25 years,
Howard specialised in developing
pharmacy procurement services at trust, regional and
national levels with a particular emphasis on audit and
patient safety, whilst using appropriate technology.
Howard was the Founder Chairman of the GHP
Procurement and Distribution Interest Group, (PDIG)
which continues to drive forward “best practice” and
facilitates communication across the NHS and industry.
Howard now has over five years experience in the
pharmaceutical industry. He is currently Senior
Commercial Development Manager for Pfizer Ltd,
providing the national lead for NHS pharmacy
contracting and procurement activity. Howard is also
the secretary of the ABPI NHS Supply Chain Group
and also represents the pharmaceutical industry on the
GHP PDIG Committee.
Allan Karr
Pharmacy Business Services Manager,
University College London Hospitals Trust
and Chairman, GHP Procurement and
Distribution Interest Group
Allan Karr has worked within a number
of London teaching hospitals, including St Mary’s, Royal
Brompton and St. Stephen’s in a wide variety of
capacities for the last 25 years. He is currently employed
as the Pharmacy Business Services Manager for
University College London Hospitals Trust. This post
enables him to cover a range of interests and develop a
number of initiatives. One of these initiatives included
the development of “Solutions” which is a
newsletter/website aimed towards those involved in
procurement and distribution.
The business unit at UCLH is regarding as a commercial
centre providing a wide range of products and services to
local trusts. Allan, together with other key staff, has led
the expansion of the unit that now has a turnover of over
medicines valued at £50 million. Allan is member/chair of
a number of local, regional and national committees
which include Chairman of the Procurement and
Distribution Interest Group (GHP), the National Home
Care Services Committee, the London Regional Formulary
and Medicines Evaluation Steering Committee.
ABSTRACTS &
BIOGRAPHIES
His research interests include designing and evaluating
tools to test pharmacists’ competence to undertake
current and future roles. He has published widely in
this and other fields of pharmacy practice.
15
ABSTRACTS & BIOGRAPHIES
16
ABSTRACTS &
BIOGRAPHIES
2G: Care closer to home and medicines
management in managed care
3B: Succession planning:
Experiential development plan
How can hospital pharmacists work with primary care
health professionals to keep patients who have frequent
unplanned hospital admissions at home? This workshop
will consider how pharmacists can play a greater role in
managed care of vulnerable people. Participants will
gain an understanding of the key roles for case
managers and the potential of medicines management
and pharmacists to contribute to case management.
The workshop will give delegates a number of different
ideas to make this happen in each local health economy.
We are increasingly aware of the importance of
leadership across all professions in healthcare today.
With new and emerging technologies, an ageing
society, increased chronic diseases and co-morbidities,
the challenges for appropriate medicines management
have never been greater. The evolving roles and
responsibilities for the pharmacy profession require the
development of leadership to ensure we are equipped
for the future. The three workshops will address
leadership issues that are relevant to the current
changes within the NHS.
Sue Carter
During the third workshop, we plan to explore the
delegates’ perceptions of leadership and the qualities
needed to become leaders. We will take an interactive
approach to use the delegates’ own experiences and
examples of how they have learnt leadership skills
through their development alongside an overview of
the different methods used to attain leadership skills.
We plan to focus on the use of experiential learning as
one way to develop these skills.
Head of Prescribing & Pharmacy, Adur, Arun & Worthing PCT
and Member of Council, Guild of Healthcare Pharmacists
See page 13 for Sue’s biography.
3A: The skills escalator and the KSF
Recent changes in the grading of hospital pharmacy
staff have probably left many people with less clarity
than they ever had over their career development.
Many young pharmacy staff have never fully
understood what career opportunities are open to
them and, more importantly, what they have to do to
take advantage of them. The terminology and
systems used to facilitate career development can be
very confusing, particularly to inexperienced staff.
This workshop aims to explore ways to outline how a skills
escalator may be built allowing staff to easily and quickly
understand how career progression can be achieved, and
more importantly, what they actually have to do to
progress. The discussion will build on the simple escalator
to show how the Knowledge and Skills Framework could
be utilised in combination to aid personal development
planning and training needs analysis.
The emphasis will be on a generic model that can be
adapted to any group of staff and will also explore
suitable tools for building the model. It is hoped that
participants will also review the ideas presented and
add their own to maximise the output of the session.
Steve Acres
Pharmacy Services Manager, Leicester
Royal Infirmary
Steve Acres spent 30 years in the
Armed Forces initially training in the
Army as a Pharmacy Technician. In
1987 he was commissioned as a
Medical Supply Officer with specific responsibility for
operational medical supply, including the 1990/91
Gulf War. Subsequently, Steve then transferred to the
RAF where he worked in operational medical planning
and support, manpower planning and medical training
and development; he was also the Trade Specialist
Officer for all RAF Pharmacy Technicians
In 2002, Steve left the Forces and worked briefly in
pharmaceutical wholesaling before joining University
Hospitals of Leicester as Chief Technician Training and
Development in March 2003. In November 2003
Steve moved into his current role.
Following this workshop, participants will be able to
identify which experiences or situations are conducive
for the development of leadership in their team; have
an overview of some theories of leadership
development and be able to identify mechanisms for
developing their personal resources. This workshop will
provide useful and relevant information for leaders in
pharmacy, we welcome all participants.
Dr Catherine Duggan
Director, Academic Department of
Pharmacy, Barts and the London NHS
Trust, Royal London Hospital
Catherine has responsibility for
integrating research into practice,
ensuring that professional education
and training is seamless and lifelong. Catherine has
published over 50 papers and articles and more than
80 abstracts and has been successful in securing
£550,000 in research income. Catherine is regularly
invited to speak at national and international
conferences and meetings, she regularly reviews
papers for academic journals and sits on several
committees to judge grant applications. Catherine is a
member of an ethics committee and has been
commissioned to work at the Department of Health to
co ordinate pharmacy R&D at policy level.
Pippa Roberts
Chief Pharmacist, Wirral Hospital NHS
Trust and GHP/UKCPA Leadership
Development Group
Pippa moved to Wirral Hospitals NHS
Trust (WHT) as the Director of
Pharmacy and Medicines Management
in August 2005.
In the year prior to this Pippa worked as the Director
of Governance and Corporate Affairs at Chelsea and
Westminster Hospital with Trust Board responsibility
for integrated governance, legal affairs,
communication and PR and corporate affairs.
ABSTRACTS & BIOGRAPHIES
Pippa joined Chelsea and Westminster Hospital in
September 1997 and became the Chief Pharmacist in
February 1998. Prior to the move to London in
September 1997, she worked for five years in the
Oxford Radcliffe NHS Trust within a variety of patient
services and clinical roles.
3C: Acute coronary syndromes
We will look at the pathophysiology behind the spectrum
of acute coronary syndromes and common tests used in
the emergency department in the diagnosis – including
an attempt to demystify the 12-lead ECG! We will then
have a look at current evidence about initial anti-platelet
therapy in the management of ACS, strategies for the
immediate management of unstable angina and non-ST
elevation myocardial infarction as well as the reperfusion
options for ST elevation myocardial infarction. Hopefully
all this will be made even clearer by working through
some case studies – although not in too heavy a manner
for a Sunday morning!
Jennifer Thomson
Clinical Pharmacist, A&E & Outreach,
Southampton General Hospital
Jennifer studied pharmacy at
Strathclyde University before moving
to Colchester to finish her training. She
has been working at Southampton General since
2000. She spent 30 months on clinical rotation
working in orthopaedics, general surgery,
neurosciences, medicine and cancer care – valuable
experience for her current post as A&E and Outreach
pharmacist where she’s been since June 2003. Her
time is split between developing the role of the
pharmacist in A&E, covering critical care services, links
with the critical care outreach team and providing
surgical ward cover. She also has a teaching
commitment within pharmacy, for other hospital staff
and medical undergraduates.
3D: Rheumatology
Rheumatoid arthritis is a complex disease with
consequences that extend far beyond the visible
damage to patients' joints. The treatment of this
disease has changed in approach in a number of ways,
and further changes are expected in the near future.
The session will begin with an overview of the causes
and social implications of rheumatoid arthritis and
some of the more useful statistics. This workshop has
then been structured to follow a course of a patients
disease and look at the social difficulties, treatment
options available at each stage and the
common outcomes of following this treatment. This
workshop will review changes in the treatment of
rheumatoid arthritis and the new drugs that are
available, or soon to be available to treat patients.
Where possible, the evidence base will be reviewed.
As well as looking at the more traditional drugs and
the increasing trend to use them in more aggressive
regimens, the session will look at the physiology and
rationale behind the use of anti-TNF therapies, B-cell
and T-cell modulation and some of the safety concerns
that have since arisen. NICE guidance affecting
rheumatology will also be reviewed.
Dr Christopher Green
Director of Pharmacy and Medicines
Management, Countess of Chester NHS
Foundation Trust
Dr Green is the Director of Pharmacy
and Medicines Management at the
Countess of Chester NHS Foundation
Trust. He is also an Honorary Lecturer at the School of
Pharmacy and Chemistry at the Liverpool John Moores
University and has been a General Committee member
of the United Kingdom Clinical Pharmacy Association
for five years. His main interest is clinical pharmacy
services and he has been involved in research with
regard to adverse drug reactions and pharmacy
practice for almost a decade and has pursued an
interest in rheumatology and safe medication practice
during this time.
3E: Implementing solutions:
Understanding the dynamics of
multidisciplinary team working
In healthcare, we often work with multidisciplinary
teams. Patient safety is no exception. Understanding
how teams work, therefore, is an important skill to
today’s pharmacists, helping us to adopt a role within
a team. We also need to develop the versatility to
adapt that role, depending on the team dynamic, in
order to get the most effective solution.
In this workshop we will look at what makes an effective
team. We will look at team resource management
(human factors and team working). We will then look at
how the multidisciplinary approach can best work, what
barriers there may be, and how to overcome them.
The workshop will be a mixture of presentation and
participation.
Amanda McLean
Quality Assurance Pharmacist, Western
General Hospital Edinburgh and Chair,
UKCPA Quality and Risk Management
Group
Amanda McLean is Chair of the UKCPA
Quality and Risk Management Group.
She has been a quality assurance pharmacist at the
Western General Hospital in Edinburgh for 12 years.
Her role there has been to develop quality systems for
pharmacy processes for Lothian Hospital Pharmacies,
and maintain accreditation to ISO 9001:2000 by
auditing these processes against the Standard. More
recently her role has expanded to include risk
ABSTRACTS &
BIOGRAPHIES
This session will look at the initial management of
Acute Coronary Syndromes (ACS) focussing on the
treatment given in the emergency department and
admissions areas. The aim of this session is for
participants to learn how to improve the initial
management of patients with ACS.
17
18
management, with a focus on patient safety and
developing systems to promote this.
Amanda has been actively involved in the UKCPA for
many years, and has been on the QRM committee for
nine years.
ABSTRACTS &
BIOGRAPHIES
3F: An overview of Colorectal Cancer
Colorectal cancer is the 2nd most common
malignancy after lung and affects 35,000 patients in
the UK each year. An awareness of the symptoms
associated with this disease is vital in order to achieve
the best chance of cure with an early diagnosis and
appropriate surgical treatment. The national bowelscreening programme has now been delayed.
It is a very exciting time in the treatment of colorectal
cancer as there have been recent developments in
chemotherapy which has provided the opportunity
for treating patients earlier in their disease and for
patients with advanced disease with combination
chemotherapy. Fluorouracil has been the main stay of
treatment since the 1950’s and now combination
with oxaliplatin or irinotecan, as well as the addition
of new targeted therapies, has shown improved
efficacy with increased survival benefits. Oral
fluoropyrimidines are now likely to supersede
fluorouracil in the adjuvant setting and a decision is
expected by NICE in April 2006.
This workshop will discuss the various treatment
options detailing drug toxicity and the impact of oral
chemotherapy on the way chemotherapy is now
delivered to patients. The workshop will then consider
three case studies in order to explore problems
associated with chemotherapy used in the
management of colorectal cancer patients.
Jane Ashton
RMH Specialist GI Oncology Pharmacist, Royal Marsden
NHS Trust
Jane has been working at The Royal Marsden Hospital
for the past two and a half years initially as a Clinical
Services Support Pharmacist and more recently as the
GI Specialist Pharmacist. Her current role has allowed
her to focus principally on the pharmaceutical care of
GI patients receiving chemotherapy on and off study.
Jane is a member of the Oral Chemotherapy Working
Party within pharmacy which looks at ways of
reducing the risks around all aspects of oral
chemotherapy and presented a poster detailing their
work at BOPA 2004.
Lynn Shand
Clinical Services Manager, Royal Marsden NHS Trust
3G: Care closer to home and the interface
A number of significant changes have been
announced recently which will affect the primary and
secondary care interface. These include:
Practice Based Commissioning and PCT mergers
The White paper “Healthcare closer to home”
The workshop will start with a brief introduction to
these changes and the implications for secondary care
and the interface. Delegates will then consider how
they might want to redesign hospital pharmacy
services to provide services that maximise hospital
income; full-fill the needs of new commissioning
groups and the changing expectations of patients.
The aim of the workshop is to consider how hospital
pharmacy services and primary care pharmacy teams
might work together better to be more responsive to the
modernisation agenda of the NHS. By the end of this
session delegates will understand the implications of
practice based commissioning and public/private
providers on the secondary to primary care shift and have
a vision and plan for how they will redesign outpatient,
interface and cross-sector pharmaceutical services.
Sue Carter
Head of Prescribing & Pharmacy, Adur, Arun & Worthing PCT
and Member of Council, Guild of Healthcare Pharmacists
See page 13 for Sue’s biography
Dr Duncan Petty
Practice Pharmacist, North Bradford PCT and Pharmacy
Lecturer, University of Leeds
www.aah-hospitalservice.co.uk
AAH Hospital Service is pleased to
support the 2nd GHP/UKCPA Joint
Conference, 12–14 May 2006
We are delighted to announce the launch
of our Added Value Services at this event
and invite you to come and visit us on
stand 37 to find out how we can help
hospital pharmacies take cost out of the
pharmaceutical supply chain.
“AAH Hospital Service
provides a robust, reliable
service and gives confidence
in the consistency and
continuity of the pharmacy
supply chain”
Karen Care,
Chief Technician
Purchasing & Distribution
and Lynne Dawson,
Senior Technician,
Royal Wolverhampton
Hospitals
“When I think AAH I think
delivering excellence in
pharmacy procurement!”
Dr David Jones,
Director of Pharmacy
Poole General Hospital
“We chose AAH as our
strategic partner because
they gave us the best and
surest route to our mission,
which is to deliver cost and
service improvements to the
health community through
supply chain efficiencies.”
Richard Ward
Director of Purchasing for the
Bristol and Weston NHS
Purchasing Consortium &
Chair of the AGW Supply
Management Confederation
EXHIBITOR LIST
EXHIBITION
LIST
20
AAH Hospital Services . . . . . . . . . . . . . . 37
Lilly UK . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Aguettant Ltd . . . . . . . . . . . . . . . . . . . . . 14
Macopharma . . . . . . . . . . . . . . . . . . . . . . 32
ARX Ltd . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Martindale Specials . . . . . . . . . . . . . . . . 12
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . 43
Medac UK . . . . . . . . . . . . . . . . . . . . . . . . 42
B Braun Medical Ltd . . . . . . . . . . . . . . . . 28
Merck Pharmaceuticals . . . . . . . . . . . . . . 29
Baxa Ltd . . . . . . . . . . . . . . . . . . . . . . . . . 35
Pharmaceutical Press . . . . . . . . . . . . . . . 23
Baxter Healthcare . . . . . . . . . . . . . . . . . 19
Robopharma UK . . . . . . . . . . . . . . . . . . . 34
Bayer Plc . . . . . . . . . . . . . . . . . . . . . . . . . 24
Rosemont Pharmaceuticals . . . . . . . . . . . 30
B M Browne UK Ltd . . . . . . . . . . . . . . . . 45
Sanofi-Aventis . . . . . . . . . . . . . . . . . . . . . 15
Doncaster & South Humber NHS Trust . 46
Servier Laboratories Ltd . . . . . . . 20 and 21
Durbin Plc . . . . . . . . . . . . . . . . . . . . . . . . 31
Sintek Ltd . . . . . . . . . . . . . . . . . . . . . . . . 13
Goldshield Hospital Europe . . . . . . . . . . 22
Syner-Med (PP) Ltd . . . . . . . . . . . . . . . . 21
GlaxoSmithKline . . . . . . . . . . . . . . . . . . . 25
Teva Hospitals . . . . . . . . . . . . . . . 26 and 27
Hameln Pharmaceuticals . . . . . . . . . . . . 16
The Specials Laboratories Ltd . . . . . . . . 33
IDIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Wockhardt UK Ltd . . . . . . . . . . . . . . . . . 17
Wyeth Pharmaceuticals . . . . . . . . . . . . . 18
To
Workshops
To Conference
To Conference
Posters
Registration
Posters
13
12
14
32
19
24
29
22
23
28
26
30
25
Ca
te
rin
gP
oin
31
35
36
18
21
27
34
33
38
17
To
Conference
t
37
16
15
To
Conference
Catering Point
EXHIBITION
PLAN
EXHIBITION PLAN
40
41
42
Catering Point
43
44
45
46
E X H I B I T O R I N F O R M AT I O N
AAH Hospital Service
37
In the year that we celebrate our 30th anniversary of
distributing pharmaceuticals to hospitals we are
pleased to launch our range of added value services
for the pharmaceutical supply chain.
As a specialist division of AAH Pharmaceuticals Limited,
we are the leading distributor of pharmaceuticals to
hospital pharmacies in the UK. We are a full line
wholesaler delivering cost and service improvements
through supply chain efficiencies
Our wide distribution capabilities means the service we
provide is at a ‘local’ level servicing every corner of the
UK from our 11 dedicated hospital branches ideally
placed locally to our customers. This service is 24
hours a day, 365 days a year, usually twice daily.
Sapphire Court, Walsgrave Triangle, Coventry CV2 2TX
Tel: 02476 432 290 Email: aah.hs@aah.co.uk
Web: www.aah-hospitalservices.co.uk
Aguettant Ltd
14
44
ARX is the leading hospital pharmacy automation
supplier. ARX’s product range centres around the
ROWA Speedcase, which ARX have continued to
develop. Over 50 UK hospitals have now automated
with the ARX solution.
ARX provides the best technology with the best service,
in order to provide the ultimate automation solution
for each hospital pharmacy. ARX continues to offer the
most flexible and advanced solution, which includes
fully automatic loading (Prolog) and fully automatic
labelling (Prima). The latest product to be launched by
ARX is the MAX. This is a channel system designed for
dispensing fast movers at huge speeds. The proven
ARX solution continues to be the safest, fastest, most
space efficient and most complete system available.
43
Horizon Place, 600 Capability Green, Luton, LU1 3LU
Tel: 01582 836000 Fax: 01582 838000
Web: www.astrazeneca.co.uk
B Braun Medical Ltd
Thorncliffe Park, Sheffield, S35 2PW
Tel: 0114 2259000 Fax: 0114 2259111 Web: www.bbraun.co.uk
Baxa Ltd
35
Founded in 1975, Baxa is a leading manufacturer of
medical devices and systems for the safe preparation,
handling and administration of liquid medication for use in
hospitals, critical care units and alternate site pharmacies.
The range includes oral and enteral dispensers, IV
admixture tools, automated filling systems and
automated TPN compounding systems.
Baxa Corporation is a privately held company based in
the US, with subsidiaries and sales offices in the UK
and Canada; direct representation in Belgium,
Denmark, Finland, France, Germany, Luxembourg and
The Netherlands, and distribution partners worldwide.
Radius Court, Eastern Road, Bracknell, Berkshire RG12 2UP
Tel: 0870 6209002 Fax: 0870 6209003
Email: info@baxa.co.uk Web: www.baxa.com
Baxter Healthcare
19
Wallingford Road, Compton, Newbury, Berkshire RG20 7QW
Tel 01635 206000 Fax 01635 206115
Web: www.baxter.com
Bayer Healthcare Plc
24
Bayer, as a leading producer of innovative
pharmaceuticals, is committed to improving antiinfective therapy worldwide.
Bayer is a world leader in the development of anti-infectives.
The company’s product portfolio includes Ciproxin“
(ciprofloxacin), one of the most successful antibiotics in the
world, used to treat a wide range of infections.
EXHIBITION
INFORMATION
Unit 6, Beaumont Works, Hedley Rd, St.Albans AL1 5LU
Tel. 01727 893360 Fax. 01727 893361
Email: sales@arxinter.net Web: www.arxinter.net
AstraZeneca
B. Braun are pleased to present you Ecoflac® plus a
new concept in IV solutions, offering an increased
focus on the safe administration of a wide range of
intravenous solutions. Please visit stand No. 28 for
further information on this product innovation.
All of our products and systems are designed to
streamline pharmacy practice, enhance patient safety
and reduce operating costs.
Bishops House, Bishops Road, Claverham Somerset BS49 4NF
Tel: 01934 835 694 Fax: 01934 876 790
Email: info@aguettant.co.uk Web: www.aguettant.co.uk
ARX Ltd
21
Most recently Bayer has launched Avelox“
(moxifloxacin), a fluoroquinolone antibiotic for the
treatment of community-acquired pneumonia and
acute exacerbations of chronic bronchitis.
Bayer House, Strawberry Hill, Newbury, Berkshire RG14 1JA
Tel: 01635 563000 Email: medical.science@bayer.co.uk
Web: www.bayer.co.uk
28
B. Braun Medical Ltd is a member of the B. Braun
Group, one of the worlds leading healthcare companies.
The B. Braun Group manufactures and distributes in
over 50 countries and employs over 26,000 people.
B. Braun has a reputation for expertise and standard
setting which is built on 160 years experience. We
offer an outstanding range of healthcare products,
matched by comprehensive, high quality services. Our
success reflects our innovative ability to develop new
products, services and systems, often in partnership
with hospitals, universities and other specialists.
B M Browne UK Ltd
45
B M Browne (UK) Ltd is a leading distributor of high
quality products. Our comprehensive product portfolio
includes:
Pharmaceutical
Medical
Surgical
Dialysis
Laboratory
Brownes was founded in 1992 and is part of DCC plc.
The pharma division of Brownes was set up in 2003
with the mission to offer high quality generic IV
pharmaceuticals to the UK. Our experienced team
offers excellent support and specialises in creating
E X H I B I T O R I N F O R M AT I O N
22
lasting partnerships with our customers. We plan to
launch many new products into the IV generic market
over the next few years – continuing our strategy of
good design, quality and competitive pricing.
Pincents Kiln Industrial Park, Calcot, Reading RG31 7SB
Tel: 0118 930 5333 Fax: 0118 930 5111
Email: enquires@bmbrowne.co.uk Web: www.bmbrowne.co.uk
Doncaster & South Humber NHS Trust 46
Specialist Mental Health Pharmacist Taster Sessions.
Have you ever considered a change in career? Why
not find out what working as a specialist mental health
pharmacist involves. Come and visit us on stand 46
As part of the new ways of working initiative we have
set up a taster session in specialist mental health
pharmacy. We will give you a chance to spend a tailor
made day working with a specialist pharmacist
designed to suit your requirements. Come and spend
a day at our expense, it might be the beginning of a
new career. For further information contact Andrew
Houston on 01709 307158.
St Catherines House, Tickhill Road, Balby, Doncaster DN4 8QN
Tel: 01709 307158
Durbin Plc
31
Durbin PLC has a strong reputation for sourcing hardto-find medicines and delivering products promptly in
critical emergency situations
Combining an ever-increasing database of products,
over 40 years of exports experience and specialist
knowledge of the UK pharmaceutical import market,
Durbin PLC offers tailored services to supply the
following categories of medicine: Unlicensed/‘namedpatient’ medicines; UK discontinued products; UK
supply shortages and orphan drugs.
EXHIBITION
INFORMATION
Dipti Amin, Pharmaceutical Services Manager, says:
“We gained over 100 new regular customers last year
after they initially contacted us in a critical shortage
situation and came back after they experienced our
excellent service. We’ve never been busier!”
Durbin House, 180 Northolt Road, Harrow, Middlesex HA0 2LT
Tel: 020 88696500 Web: www.durbin.co.uk
Goldshield Hospital Europe
22
Goldshield Hospitals are the suppliers of generic injectable
products including Antigen Pharmaceuticals, Goldshield
Oncology range and Goldshield Pharmaceuticals as part
of the national and regional tender processes within
England, Scotland, Wales and Northern Ireland.
We promote several branded pharmaceuticals for the
hospital sector including Robinul (glycopyrrolate) and
Dopram (doxapram), Autodetect (A loss of resistance
Syringe and Noseeze - a Sesame based oil for the nasal
tissues). Our supply of Bupivacaine infusion solution is
the only licensed product on the market. To further
extend our infusion bag range, we have recently
developed Bupivacaine specials, which are available
upon on request.
As part of our mission to further improve the supply,
distribution and service, we have implemented a move
to a dual source of the distribution channel direct to
hospitals through UniDrug Group and Healthcare
Logistics Ltd.
NLA Tower, 12-16 Addiscombe Road, Croydon, Surrey CR0 0XT
Tel: 0208 649 8500 Fax: 0208 686 0807
Email: info@goldshieldplc.com Web: www.goldshieldplc.com
GSK
25
GlaxoSmithKline (GSK) is a research-based
pharmaceutical company with a mission to improve
the quality of human life by enabling people to do
more, feel better and live longer.
GSK makes prescription medicines, vaccines, over-the
counter medicines and consumer healthcare products.
Its business accounts for 6.3% of the world’s
pharmaceutical market. GSK has particularly strong
positions in several therapeutic areas including antiinfectives, asthma, cancer, depression, cardio-vascular,
diabetes, HIV/aids and urology.
In 2005, GSK invested £3.1 billion and employed over
15,000 people in research and development with the
aim of building the best product pipeline in the industry.
GSK makes donations of money, medicines, vaccines,
time and equipment to support good causes. In
2005, total community investment was valued at
£380 million.
Stockley Park West, Uxbridge, Middlesex UB11 1BT
Tel: 020 8990 9000 Web: www.gsk.com
Hameln Pharmaceuticals
16
Hameln Pharmaceuticals is a leading supplier of high
quality sterile generic injectables to the UK secondary
healthcare sector. Supplying the NHS for the last 35
years, Hameln Pharmaceuticals has gained a deserved
reputation for delivering quality, consistency and
reliability throughout its operations. Patient safety is at
the forefront of every element of the Hameln service
from packaging designed to reduce medication errors,
to in-group production and logistics facilities to ensure
reliability of supply. For further information on our
products, service or packaging design, please visit our
website: www.hameln.co.uk or contact us at
enquiries@hameln.co.uk.
Nexus, Gloucester Business Park, Gloucester, GL3 4AG
Tel: 01452 621661 Fax: 01452 632732
Email: enquiries@hameln.co.uk Web: www.hameln.co.uk
IDIS
36
IDIS, the first choice for sourcing named-patient
medicines is the only full-service named-patient
specialist organisation delivering free sourcing and
technical support advice, ensuring all regulatory and
legislative complexities are met and that medicines are
ethically supplied.
Our extensive experience makes us the global experts
in the provision of ethical supply solutions. Free
sourcing from our database of over 20,000 medicines
(updated daily) means you can meet the most
challenging requirements – quickly and efficiently.
IDIS is committed to providing pharmacists the
optimal service. Contact our Customer Services Team
on 01932 824100, or visit www.idispharma.com for
more information.
E X H I B I T O R I N F O R M AT I O N
Merck Pharmaceuticals
Idis House, Churchfield Road, Weybridge, Surrey KT13 8DB
Tel: 01932 824 100 Email: enquiries@idispharma.co.uk
Web: www.idispharma.com
Lilly UK
38
Lilly House, Priestly Road, Basingstoke, Hampshire, RG24 9NL
Web: www.lilly.com
Macopharma
32
MacoPharma is an innovator in global healthcare with
expertise in the fields of transfusion and infusion. The
company has become the largest supplier of closed
systems in Europe and is expanding its efforts into the
biotherapy and transfusion fields by developing
innovative products.
One of MacoPharma's aims is to provide a
comprehensive range for the customers. This is
conducive with the MacoPharma product
development strategy of the continuous quest,
through partnerships, for improved safety, efficacy,
and quality of transfusion, infusion and biotherapy.
Robopharma UK
12
At Martindale Specials we apply our quality
assurance, formulation and manufacturing
capabilities to producing a wide range of special
presentations, including sterile ampoules, aseptic eye
drops and ointments as well as non-sterile oral
liquids, topical preparations, suppositories, pessaries,
powders and capsules.
Martindale Specials' all-embracing approach to
customer service is fundamental to our success. We
take pride in fulfilling orders within the quoted leadtimes, and strive to offer a consistent and reliable
service. Our freephone customer services number is
0800 137 627.
23
42
Medac are delighted to be at the 2nd GHP/UKCPA
joint conference 2006. This month we are proud to
announce the UK launch of the first and only licensed
range of Methotrexate pre-filled syringes METOJECT®
for Rheumatoid Arthritis. (www.metoject.com).
Medac is an innovative German pharmaceutical
company with a well established research-based
reputation and experience in oncology, haematology,
fibrinolysis and autoimmune disease. We are a team of
healthcare and industry professionals, many with
relevant hands on experience. We are dedicated to
providing a high quality and efficient service.
34
RoboPharma UK is an innovative rapidly developing
supplier of automated pharmacy dispensing solutions
to the NHS and community pharmacy markets. A
dispensing speed of 3-80 products per second, loading
speed of up to 1000 products per hour along with a
fast transportation system to any number of drop off
points including ward box filling ensures the
RoboPharma system provides the optimum solution for
any busy pharmacy. RoboPharma`s in house software
development team ensures an interface is provided for
any PMR software system and service contracts are
maintained by its UK based service engineers.
Jason House, Hillam Road, Bradford, West Yorkshire, BD2 1QN
Tel: 01274 395588 Contact: Neil Clifford
Email:sales@robopharma.co.uk Website: www.robopharma.co.uk
Rosemont Pharmaceuticals
30
Rosemont Pharmaceuticals Ltd. is a leading developer,
manufacturer and distributor of high quality, oral
liquid medicines with a product range of more than
90 different drugs.
We are also dedicated to the promotion of best
practice, when administering medication. We provide
training sessions and hospital speaker meetings, which
contribute to Continuing Professional Development.
Our award-winning educational materials, which are
available to all healthcare professionals, include patient
information leaflets, a medication management
booklet, swallowing difficulties protocol and an oral
liquid formulary.
Rosemont House, Yorkdale Industrial Park, Braithwaite Street,
Leeds LS11 9XE
Tel: 0113 244 1400 Email: infodesk@rosemontpharma.com
Web: www.rosemontpharma.com
Sanofi-Aventis
One Onslow Street, Guildford, Surrey GU1 4YS
Tel. 01483 505 515 Fax : 01483 535 432
Web: www.sanofi-aventis.co.uk
15
EXHIBITION
INFORMATION
Hubert Road, Brentwood, Essex CM14 4JY
Tel: 01277 266600 Email: info@cardinal.com
Web: www.cardinal.com
Tel: 01786 458086 Fax: 01786 458032
Email: info@medac-uk.co.uk
Web: www.medac.de or www.metoject.com
Harrier House, High Street, West Drayton, UB7 7QG
Tel.: 01895 452200 Fax: 01895 420605
Email: enquiries@merck-pharmaceuticals.co.uk
Web: www.merck-pharmaceuticals.co.uk
1 Lambeth High Street, London SE1 7JN
Tel: 020 7735 9141 Fax: 020 7735 7629
Email: enquiries@rpsgb.org Web: www.pharmpress.org
Already one of the UK’s major suppliers of specials,
Martindale Specials is committed to setting and
enhancing industry standards.
Medac UK
29
Merck is a global pharmaceutical and chemical company
with sales of EUR 5.9 billion in 2005, a history that
began in 1668, and a future shaped by 29,133
employees in 54 countries. Its success is characterized by
innovations from entrepreneurial employees. Merck's
operating activities come under the umbrella of Merck
KGaA, in which the Merck family holds a 73% interest
and free shareholders own the remaining 27%. The
former U.S. subsidiary, Merck & Co., has been
completely independent of the Merck Group since 1917.
Pharmaceutical Press
8th Floor, Regal House, 70 London Road, Twickenham,
Middlesex TW1 3QS Web: www.macopharma.com
Martindale Specials
23
E X H I B I T O R I N F O R M AT I O N
24
Servier Laboratories Ltd
20 and 21
Servier Laboratories Limited is the British Subsidiary of
the Servier Research Group, a leading French based
organisation specialising in ethical pharmaceuticals.
Servier is currently within the top 15 largest
pharmaceutical companies in the UK.
Servier’s product portfolio in the UK focuses on the
therapeutic areas of Cardiovascular disease, Diabetes,
Osteoporosis and soon Depression. Servier's R&D
pipeline is extremely healthy having the potential to
submit one product for license every year for the
next eight to ten years. Servier UK and the whole
Servier Research Group is set for dramatic growth
over this period.
Wexham Springs, Framewood Road, Wexham, Slough,
Berkshire SL3 6RJ
Tel: 01753 662744 Fax: 01753 663456
Email: info@uk.netgrs.com Web: www.servier.co.uk
Sintek Ltd
Email: sintekltd@mac.com Web: www.sintek.se
21
Venofer® (IV Iron Sucrose)
Safety is the primary concern regarding the
administration of parenteral iron, and the European Best
Practice Guidelines for the management of renal
anaemia state “Iron sucrose is generally considered to be
the safest form of IV iron”. Venofer® is of proven
efficacy in overcoming the limitations of oral iron and is
used for the treatment of anaemia associated with blood
loss (surgery, inflammatory bowel disease), increased
iron demands (pregnancy), and to enhance the efficacy
of erythropoietin therapy (renal and cancer related
anaemia). Venofer® (IV iron sucrose) has come to be the
most widely prescribed parenteral iron in the UK.
Beech House, 840 Brighton Road, Purley, Surrey CR8 2BH
Tel: 0845 634 2100 Fax: 0845 634 2101
Email: mail@syner-med.com Web: www.syner-med.com
EXHIBITION
INFORMATION
Teva Hospitals
33
The Specials Laboratory manufactures and delivers
unlicensed medicines to thousands of pharmacies
across the UK.
Our award-winning company is run by Pharmacists
who understand the increasing day-to-day pressures in
the dispensary, which is why we’re committed to
providing such a knowledgeable and personal service.
‘The Lab’ provides a unique combination of an
exceptional manufacturing capability and an unrivalled
service that constantly exceeds customer expectation.
As always, standard delivery time is 24-48 hours.
We look forward to seeing you at stand 33 and
welcome the opportunity to talk to you about your
service requirements and our current job vacancies.
Unit 1 Regents Drive, Low Prudhoe Industrial Estate,
Northumberland NE42 6PX
Tel: 0800 028 4925 Web: www.specialslab.co.uk
13
Syner-Med (PP) Ltd
The Specials Laboratory Ltd
26 and 27
Wockhardt UK Ltd
17
Wockhardt UK is a diverse pharmaceutical business
supplying healthcare products to the hospital, retail
and grocery sectors. We are a leading supplier to the
hospital market and have an extensive product range
that includes opioid analgesics, anti-infectives,
anticoagulants and cytotoxics.
The Wockhardt group plans to further develop this
injectable portfolio by investing heavily in new
products developed at its world-class R&D facility.
With the support of our parent company, Wockhardt
UK can build upon our heritage as CP Pharmaceuticals
to ensure the ongoing provision of first rate products
and services. To find out more please visit our new
website at www.wockhardt.co.uk.
Ash Road North, Wrexham Industrial Estate, Wrexham LL13 9UF
Tel: 01978 661261 Fax: 01978 660130
Web: www.wockhardt.co.uk
Wyeth Pharmaceuticals
18
Wyeth welcomes all GHP/UKCPA delegates and invites
you to visit us at our stand.
Specialising in oncology injectables and a broad range
of solid dose products, we are dedicated to setting
new standards in the safe handling of hazardous
products. Teva Hospitals has an extensive pipeline of
hospital products and is well on its way to becoming a
major partner to the UK Hospital sector.
Wyeth is one of the UK's leading pharmaceutical
companies with a significant commitment to clinical
research. Wyeth is committed to working in partnership
with Government, healthcare professionals and patient
support organisations to continue to enhance the
quality of life for as many people as possible.
Teva Hospitals is committed to improving safety for
healthcare professionals. Tevadaptor will be launched
in the near future and is a closed device to minimise
exposure during the transfer and adminstration of
hazardous products. Teva Hospitals will shortly
introduce its new packaging across our portfolio.
Worldwide, the company focuses on finding
groundbreaking medical therapies, and has a broad
portfolio of leading products across a wide range of
therapy areas.
“Teva is the largest generic drug company in the
world and ranks 16th among all pharmaceutical
companies.”
Leeds Business Park, 18 Bruntcliffe Way, Morley, Leeds, West
Yorkshire LS27 0JG Tel: 0800 783 8382 Fax: 0113 201 3942
Email: customer.services@tevahospitals.co.uk
Web: www.tevahospitals.co.uk
Huntercombe Lane South, Taplow, Maidenhead SL6 0PH
Tel: 01628 604377 Fax: 01628 666368 Web: www.wyeth.com
E VA L U AT I O N F O R M
Please take a few minutes to answer the questions below. Your feedback is important to us and will
help us to develop future events.
Please state your job title
NHS Trust
Self
Employer
Other
GHP UKCPA Both Neither How was your delegate fee funded?
Are you a member of:
Please evaluate the sessions you attended, scoring from 4-1 (4 – excellent; 1 – poor)
Keynote: Standardised medication management
Ian Coombes
Satellite meetings
Gastroenterology
John Anderson and Omar Ali
4
3
4
2
1
3
2
1
3
2
1
3
2
Comments:
Comments:
UKCPA Annual General Meeting
4
Plenary speakers
Comments:
Delivering the future in stormy weather
Dr Keith Ridge
4
3
2
1
GHP Meeting
4
Comments:
1
Comments:
Medicines management in Northern Ireland
Dr Mike Scott
4
3
2
1
The future of extending prescribing
Tony Avery
4
Comments:
3
2
1
2
1
Comments:
Internet-based medication safety package
Prof Bryony Dean-Franklin
4
3
2
1
Modernising regulation
Robert Darracott
4
Comments:
3
Comments:
Medicines management course for pharmacy
technicians
Dr Sheila Woolfrey
4
3
2
1
Comments:
3
2
1
3
2
1
EVALUATION
FORM
Comments:
4
Comments:
Collegial model of management
Laura O’Loan
4
Agenda for Change
David Miller
E VA L U AT I O N F O R M
Social events
The venue
4
Friday 12 May: ‘A taste of Asia’
4
3
2
1
3
2
1
3
2
1
2
1
Comments:
Comments:
The catering
4
Saturday 13 May: Conference dinner
4
3
2
1
Comments:
Comments:
The accommodation
4
The exhibition
3
Comments:
Did you visit the exhibition?
Yes
No
What was the highlight of the conference for you?
How useful was the exhibition?
4
3
2
1
Comments:
What was the least useful part of the conference?
Did you learn anything new from the exhibitors’?
Yes
No
How would you like to see GHP/UKCPA joint national
conference develop in the future?
Comments:
Who else would you like to see exhibit at future events?
Conference management
What topics would you like to see addressed at future
events?
Any additional comments?
Pre-conference administration and registration
4
3
2
1
2
1
Comments:
Onsite management
4
3
EVALUATION
FORM
Comments:
Many thanks for completing this form.
Please return to the registration desk or post/fax to:
Profile Productions Ltd, Northumberland House, 11 The Pavement, Popes Lane, London W5 4NG
Tel: 020 8832 7311 Fax: 020 8832 7301
A leading supplier of
generic hospital
products
A leading supplier to the Hospital market with an
extensive product range
Injectable portfolio development via our parent
company’s world-class R&D facility
A diverse pharmaceutical business, supplying healthcare
products to the Hospital, Retail and Grocery sectors
For more information, please visit our new website at
www.wockhardt.co.uk where you will find:
– A fully searchable Product Catalogue
WUK02/06 April 2006
– Easy communication via the Contact Us page
Wockhardt UK Limited, Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF, UK
Tel: +44 (0)1978 661261 Fax: +44 (0)1978 660130
www.wockhardt.co.uk
At IDIS we don’t leave
anything to chance
With the level of quality assurance we strive to deliver, it’s no
wonder we’re always your first choice for sourcing named-patient medicines
and providing all the support and service that it involves. That’s because we
understand you can’t leave anything to luck or chance, which is why we always
make every effort to satisfy any request, no matter how large or small.
To speak to a member of our Client Services Team call +44 (0)1932 824100
or visit www.idispharma.com for more information.